Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Bulletin Du Cancer
|
January 1, 1991
[Study of vinorelbine (V) combined with hexamethylmelamine (H) (combination V-H) in adenocarcinoma of the ovary: results a phase I-IIA trial, NHO-88, of ARTAC "ovarian" group]
G Pinon, M C Pinel, M J Goudier, et al.
Bulletin Du Cancer
|
February 1, 1993
[Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients]
E Pujade-Lauraine, J P Guastella, N Colombo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2008
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
F-C Bidard, A Vincent-Salomon, B Sigal-Zafrani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2010
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
L Staudacher, P H Cottu, V Diéras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2010
Survival of breast cancer patients with meningeal carcinomatosis
H Gauthier, M N Guilhaume, F C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
J-Y Pierga, D Hajage, T Bachelot, et al.
Breast (Edinburgh, Scotland)
|
September 22, 2015
Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study
D Chocteau-Bouju, C Chakiba, L Mignot, et al.
Cancer Letters
|
February 22, 2015
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial
C Helissey, F Berger, P Cottu, et al.
Journal of Neuro-Oncology
|
September 18, 2013
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa
A Comte, W Jdid, M N Guilhaume, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2009
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer
F-C Bidard, Y M Kirova, A Vincent-Salomon, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Bulletin Du Cancer
|
January 1, 1991
[Study of vinorelbine (V) combined with hexamethylmelamine (H) (combination V-H) in adenocarcinoma of the ovary: results a phase I-IIA trial, NHO-88, of ARTAC "ovarian" group]
G Pinon, M C Pinel, M J Goudier, et al.
Bulletin Du Cancer
|
February 1, 1993
[Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients]
E Pujade-Lauraine, J P Guastella, N Colombo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2008
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
F-C Bidard, A Vincent-Salomon, B Sigal-Zafrani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2010
Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
L Staudacher, P H Cottu, V Diéras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2010
Survival of breast cancer patients with meningeal carcinomatosis
H Gauthier, M N Guilhaume, F C Bidard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2011
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
J-Y Pierga, D Hajage, T Bachelot, et al.
Breast (Edinburgh, Scotland)
|
September 22, 2015
Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study
D Chocteau-Bouju, C Chakiba, L Mignot, et al.
Cancer Letters
|
February 22, 2015
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial
C Helissey, F Berger, P Cottu, et al.
Journal of Neuro-Oncology
|
September 18, 2013
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa
A Comte, W Jdid, M N Guilhaume, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 27, 2009
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer
F-C Bidard, Y M Kirova, A Vincent-Salomon, et al.
Page
of 8